Pacifica Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$394K Hold
967
– – 0.12% 86
2026
Q2
$362K Hold
967
– – 0.11% 90
2026
Q1
$340K Buy
+967
New +$345K 0.11% 89
2025
Q4
– Sell
-1,099
Closed -$328K – 451
2025
Q3
$328K Sell
1,099
-10
-0.9% -$2.9K 0.12% 92
2025
Q2
$307K Buy
1,109
+8
+0.7% +$2.27K 0.12% 86
2025
Q1
$341K Buy
1,101
+3
+0.3% +$886 0.16% 82
2024
Q4
$285K Buy
1,098
+10
+0.9% +$2.97K 0.12% 85
2024
Q3
$351K Sell
1,088
-24
-2% -$7.85K 0.14% 86
2024
Q2
$344K Hold
1,112
– – 0.15% 82
2024
Q1
$312K Sell
1,112
-11
-1% -$3.22K 0.14% 86
2023
Q4
$304K Buy
1,123
+180
+19% +$49K 0.15% 87
2023
Q3
$250K Buy
943
+300
+47% +$74.9K 0.14% 83
2023
Q2
$145K Sell
643
-3
-0.5% -$696 0.08% 105
2023
Q1
$163K Sell
646
-15
-2% -$3.68K 0.1% 99
2022
Q4
$174K Buy
661
+18
+3% +$4.82K 0.12% 91
2022
Q3
$150K Buy
643
+50
+8% +$12.1K 0.11% 94
2022
Q2
$147K Sell
593
-8
-1% -$1.96K 0.1% 105
2022
Q1
$137K Buy
601
+40
+7% +$9.19K 0.09% 108
2021
Q4
$117K Sell
561
-15
-3% -$3.17K 0.08% 121
2021
Q3
$123K Hold
576
– – 0.09% 104
2021
Q2
$141K Buy
576
+19
+3% +$4.67K 0.11% 92
2021
Q1
$140K Buy
557
+33
+6% +$7.87K 0.12% 87
2020
Q4
$117K Sell
524
-75
-13% -$17.3K 0.11% 87
2020
Q3
$152K Hold
599
– – 0.17% 77
2020
Q2
$154K Sell
599
-13
-2% -$2.97K 0.17% 76
2020
Q1
$128K Hold
612
– – 0.16% 76
2019
Q4
$148K Buy
+612
New +$135K 0.14% 81

Other funds holding AMGN

Pacifica Partners's AMGN Position: Q3 2026 in Review

Pacifica Partners held its Amgen (AMGN) position steady in Q3 2026 at 967 shares worth $394K. The position accounts for 0.12% of the portfolio, ranked #86.

Pacifica Partners first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,057 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Pacifica Partners held 967 shares of Amgen worth $394K as of Q3 2026.
  • Pacifica Partners left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.12% of Pacifica Partners's portfolio in Q3 2026, its #86 holding.
  • Pacifica Partners first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.